Vivani Medical
VANI
41 hedge funds and large institutions have $6.52M invested in Vivani Medical in 2018 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 9 closing their positions.
1,858% more call options, than puts
Call options by funds: $235K | Put options by funds: $12K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 8
0.87% less ownership
Funds ownership: 10.96% → 10.08% (-0.87%)
7% less funds holding
Funds holding: 44 → 41 (-3)
14% less capital inflows, than outflows
Capital inflows: $248K | Capital outflows: $289K
33% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$78K |
| 2 |
Psagot Value Holdings
Tel Aviv,
Israel
|
+$63.2K |
| 3 |
Weiss Asset Management
Boston,
Massachusetts
|
+$23.6K |
| 4 |
FC
Fore Capital
New York
|
+$21.6K |
| 5 |
HBK Sorce Advisory
Erie,
Pennsylvania
|
+$19.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Bank & Trust
Irvine,
California
|
-$81K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$56K |
| 3 |
Millennium Management
New York
|
-$45.6K |
| 4 |
Institutional & Family Asset Management
Fort Collins,
Colorado
|
-$24K |
| 5 |
Koshinski Asset Management
Decatur,
Illinois
|
-$21K |
VANI Hedge Fund Activity: Q4 2018 in Review
41 of the 4,506 institutional investors tracked by Wall St. Rank reported a position in Vivani Medical (VANI) for Q4 2018, worth a combined $6.52M — down 53% from $14M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of VANI and 6 opened new positions — a net loss of 3 holders — while 8 trimmed existing stakes and 8 added.
The largest buyer was Vanguard Group, adding an estimated $78K. The largest seller was Capital Bank & Trust, exiting entirely with an estimated $81K sold.
- 41 institutional investors held Vivani Medical (VANI) as of Q4 2018, down from 44 in Q3 2018.
- Funds reported $6.52M of Vivani Medical stock for Q4 2018, down 53% quarter-over-quarter.
- 6 funds opened new Vivani Medical positions in Q4 2018 and 9 closed out, a net change of -3 holders.
- The largest Vivani Medical buyer in Q4 2018 was Vanguard Group, an estimated $78K added.
- The largest Vivani Medical seller in Q4 2018 was Capital Bank & Trust, an estimated $81K sold.
Based on aggregated 13F filings for Q4 2018.